Humana said that during investor and analyst meetings it intends to reaffirm its diluted earnings per common share (EPS) outlook of approximately $15.88 for the year ending December 31, 2025.

8-KRegulation FD DisclosureFiled Mar 3, 2025Period of report Mar 3, 2025Summary published (UTC) Oct 16, 2026

Key points

AI summary

Humana said that during investor and analyst meetings it intends to reaffirm its diluted earnings per common share (EPS) outlook of approximately $15.88 for the year ending December 31, 2025.
The company said it intends to reaffirm its adjusted earnings per common share (Adjusted EPS) outlook of approximately $16.25 for 2025, which is consistent with the outlook in its press release dated February 11, 2025.
The company presented its 2025 outlook, showing GAAP EPS of approximately $15.88, plus amortization of identifiable intangibles of 0.49, and a cumulative net tax impact of non-GAAP adjustments of (0.12), to arrive at Adjusted EPS of approximately $16.25.
Humana said its senior management team is scheduled to meet with investors and analysts in various meetings from March 3, 2025 to March 31.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Reaffirms 2025 Diluted EPS (GAAP) Outlook

Humana said that during investor and analyst meetings it intends to reaffirm its diluted earnings per common share (EPS) outlook of approximately $15.88 for the year ending December 31, 2025.

Source · Based on the filing body and exhibits

Reaffirms 2025 Adjusted EPS Outlook

The company said it intends to reaffirm its adjusted earnings per common share (Adjusted EPS) outlook of approximately $16.25 for 2025, which is consistent with the outlook in its press release dated February 11, 2025.

Source · Based on the filing body and exhibits

Reconciliation of GAAP EPS to Adjusted EPS

The company presented its 2025 outlook, showing GAAP EPS of approximately $15.88, plus amortization of identifiable intangibles of 0.49, and a cumulative net tax impact of non-GAAP adjustments of (0.12), to arrive at Adjusted EPS of approximately $16.25.

Source · Based on the filing body and exhibits

Management Investor Meeting Schedule

Humana said its senior management team is scheduled to meet with investors and analysts in various meetings from March 3, 2025 to March 31.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.